# US 2024/0002870 A1 · Rapid transformation of monocot leaf explants

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0002870 A1
- Document ID: US20240002870A1
- Status: Published application
- Kind: A1
- Application number: 18/246,899
- Filed: 2021-09-28
- Published: 2024-01-04
- Earliest claimed: 2020-09-30
- Assignees: Pioneer Hi-Bred International, Inc.; Corteva Agriscience LLC
- Applicants: Pioneer Hi-Bred International, Inc.; Corteva Agriscience LLC
- Inventors: AJITH ANAND; WILLIAM JAMES GORDON-KAMM; LARISA A. RYAN; NAGESH SARDESAI; NING WANG; HUIXIA WU; XINLI EMILY WU
- Web page: https://patentgrep.com/patent/US20240002870A1

## CPC

- C07K 14/415: from plants
- C12N 15/8225: {Leaf-specific, e.g. including petioles, stomata}
- C12N 15/8201: {Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation}
- C12N 15/8205: {Agrobacterium mediated transformation}
- C12N 15/821: {Non-antibiotic resistance markers, e.g. morphogenetic, metabolic markers}
- Y02A 40/146: Genetically Modified [GMO] plants, e.g. transgenic plants
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

Methods for transforming monocot leaf explants are provided.

## Claims

### Claim 1

A method of producing a transgenic monocot plant that contains a heterologous polynucleotide comprising:
contacting a monocot leaf explant with a heterologous polynucleotide expression cassette and a morphogenic gene expression cassette, wherein the morphogenic gene expression cassette comprises a nucleotide sequence encoding a functional WUS/WOX polypeptide and a nucleotide sequence encoding a Babyboom (BBM) polypeptide or an Ovule Development Protein 2 (ODP2) polypeptide or a functional homolog of a WUS/WOX and a BBM or ODP2 polypeptide, wherein the combined expression of the nucleotide sequence encoding the functional WUS/WOX polypeptide and the nucleotide sequence encoding the Babyboom (BBM) polypeptide or the Ovule Development Protein 2 (ODP2) polypeptide or the functional homolog of a WUS/WOX and a BBM or ODP2 polypeptide is adequate in strength and duration such that the monocot leaf explant forms a regenerable plant structure containing the heterologous polynucleotide expression cassette within about eight weeks or less, or within about 6 weeks or less, or within about 4 weeks or less, or within about ten days to about fourteen days of the contacting; and
regenerating a transgenic monocot plant from the regenerable plant structure containing the heterologous polynucleotide expression cassette.

### Claim 2 (depends on 1)

The method of claim 1, wherein the monocot leaf explant is a haploid monocot leaf explant.

### Claim 3 (depends on 1)

The method of claim 1, wherein the heterologous polynucleotide expression cassette and the morphogenic gene expression cassette are introduced through a method of transformation by a Rhizobia bacterial species or particle bombardment.

### Claim 4 (depends on 1)

The method of claim 1, wherein the heterologous polynucleotide expression cassette and the morphogenic gene expression cassette are introduced through a method of electroporation, PEG transfection, or RNP (ribonucleoprotein) delivery.

### Claim 5 (depends on 1)

The method of claim 1, wherein the combined expression of the nucleotide sequence encoding the functional WUS/WOX polypeptide and the nucleotide sequence encoding the Babyboom (BBM) polypeptide or the Ovule Development Protein 2 (ODP2) polypeptide or the functional homolog of a WUS/WOX and a BBM or ODP2 polypeptide is greater than the expression of the morphogenic gene expression cassette comprising the nucleotide sequence encoding the functional WUS/WOX polypeptide operably linked to the Agrobacterium-NOS promoter having SEQ ID NO: 290 and the nucleotide sequence encoding the Babyboom (BBM) polypeptide or the Ovule Development Protein 2 (ODP2) polypeptide operably linked to the ubiquitin (UBI) promoter having SEQ ID NO: 339.

### Claim 6 (depends on 1)

The method of claim 1, wherein the monocot leaf explant is derived from a seedling and not directly derived from an embryo or a seed or an unmodified embryonic tissue.

### Claim 7 (depends on 6)

The method of claim 6, wherein the monocot leaf explant is derived from a seedling that is about 8-20 days old, about 12-18 days old, about 10-20 days old, about 14-16 days old, about 16-18 days old or about 14-18 days old.

### Claim 8 (depends on 1)

The method of claim 1, wherein the nucleotide sequence encoding the functional WUS/WOX polypeptide is selected from WUS, WUS1, WUS2, WUS3, WOX2A, WOX4, WOX5A, and WOX9, and wherein the nucleotide sequence encoding the Babyboom (BBM) polypeptide is selected from BBM, BBM1, BBM2, BBM3, BMN2, and BMN3 or the Ovule Development Protein 2 (ODP2) polypeptide is ODP2.

### Claim 9 (depends on 1)

The method of claim 1, wherein the heterologous polynucleotide expression cassette comprises a heterologous polynucleotide selected from the group consisting of:
a heterologous polynucleotide conferring a nutritional enhancement, a heterologous polynucleotide conferring a modified oil content, a heterologous polynucleotide conferring a modified protein content, a heterologous polynucleotide conferring a modified metabolite content, a heterologous polynucleotide conferring increased yield, a heterologous polynucleotide conferring abiotic stress tolerance, a heterologous polynucleotide conferring drought tolerance, a heterologous polynucleotide conferring cold tolerance, a heterologous polynucleotide conferring herbicide tolerance, a heterologous polynucleotide conferring pest resistance, a heterologous polynucleotide conferring pathogen resistance, a heterologous polynucleotide conferring insect resistance, a heterologous polynucleotide conferring nitrogen use efficiency (NUE), a heterologous polynucleotide conferring disease resistance, a heterologous polynucleotide conferring increased biomass, a heterologous polynucleotide conferring an ability to alter a metabolic pathway, and a combination of the foregoing.

### Claim 10 (depends on 1)

The method of claim 1, wherein the leaf explant is selected from the group consisting of a leaf, a radical leaf, a cauline leaf, an alternate leaf, an opposite leaf, a decussate leaf, an opposite superposed leaf, a whorled leaf, a petiolate leaf, a sessile leaf, a subsessile leaf, a stipulate leaf, an exstipulate leaf, a simple leaf, a compound leaf, leaf primordia, a leaf sheath, a leaf base, a portion of a leaf immediately proximal to its attachment point to a petiole or stem, a bud, including but not limited to a lateral bud, and a combination of the foregoing.

### Claim 11 (depends on 1)

The method of claim 1, wherein the monocot is selected from the group consisting of Panicum virgatum (switchgrass), Sorghum bicolor (sorghum, sudangrass), Miscanthus giganteus (miscanthus), Saccharum sp. (energy cane), Zea mays (corn), Triticum aestivum (wheat), Oryza sativa (rice), Pennisetum glaucum (pearl millet), Panicum spp., Sorghum spp., Miscanthus spp., Saccharum spp., and Erianthus spp.

### Claim 12 (depends on 1)

The method of claim 1, wherein the monocot is selected from the Poaceae family.

### Claim at position 13

13-17. (canceled)

### Claim 18 (depends on 1)

The method of claim 1,
wherein the functional WUS/WOX polypeptide comprises an amino acid sequence selected from SEQ ID NO: 144, 146, 148, 150, 152, 154, 156, 158, 160, 162, 164, 166, 168, 170, 172, 174, 176, 178, 180, 182, 184, 186, 188, 190, 192, 194, 196, 198, 200, 202, 204, 206, 208, 210, or 212; or wherein the functional WUS/WOX polypeptide is encoded by a nucleotide sequence selected from SEQ ID NO: 143, 145, 147, 149, 151, 153, 155, 157, 159, 161, 163, 165, 167, 169, 171, 173, 175, 177, 179, 181, 183, 185, 187, 189, 191, 193, 195, 197, 199, 201, 203, 205, 207, 209, or 211, and
wherein the Babyboom (BBM) polypeptide or the Ovule Development Protein 2 (ODP2) polypeptide comprises an amino acid sequence selected from SEQ ID NO: 214, 216, 219, 221, 223, 225, 227, 229, or 231; or wherein the Babyboom (BBM) polypeptide or the Ovule Development Protein 2 (ODP2) polypeptide is encoded by a nucleotide sequence selected from SEQ ID NO: 213, 215, 217, 218, 220, 222, 224, 226, 228, 230, or 232.

### Claim 19 (depends on 1)

The method of claim 1, wherein the morphogenic gene expression cassette further comprises a polynucleotide selected from a ZM-MIR-Corngrass1 nucleotide, a ZM-GRF5 nucleotide, a ZM-GRF4 nucleotide, a ZM-GIF1 nucleotide, a ZM-GRF4˜GIF1 nucleotide, a ZM-STEMIN1 nucleotide, a ZM-REV nucleotide, a ZM-ESR1 nucleotide, a ZM-LAS nucleotide, a ZM-CUC1 nucleotide, a ZM-CUC2 nucleotide, a ZM-CUC3 nucleotide, a ZM-RLD1 nucleotide, a ZM-KN1 nucleotide, a ZM-CYCD2 nucleotide, a ZM-GPCNAC-1 nucleotide, a ZM-MIR156B nucleotide, a ZM-LEC1 nucleotide, an AT-RKD4 nucleotide, an AT-LEC2 nucleotide, an AT-RAP2.6L nucleotide, a ZM-MIR-SPS1 nucleotide, a ZM-MIR-MAX1 nucleotide, or a ZM-MIR-MAX4 nucleotide.

### Claim 20 (depends on 1)

The method of claim 1, wherein the morphogenic gene expression cassette further comprises a polynucleotide sequence encoding a site-specific recombinase selected from the group consisting of FLP, FLPe, KD, Cre, SSV1, lambda Int, phi C31 Int, HK022, R, B2, B3, Gin, Tn1721, CinH, ParA, Tn5053, Bxb1, TP907-1, or U153, wherein the site-specific recombinase is operably linked to a constitutive promoter, an inducible promoter, a tissue-specific promoter, or a developmentally regulated promoter.

### Claim 21 (depends on 20)

The method of claim 20, further comprising excising the morphogenic gene expression cassette to provide the transgenic monocot plant that contains the heterologous polynucleotide.

### Claim 22 (depends on 1)

The method of claim 1, further comprising breeding away from the morphogenic gene expression cassette.

### Claim 23 (depends on 21)

The transgenic plant produced by the method of claim 21, wherein the plant comprises the heterologous polynucleotide.

### Claim 24 (depends on 21)

A seed of the transgenic plant of claim 21, wherein the seed comprises the heterologous polynucleotide.

### Claim 25

A regenerable plant structure derived from a transgenic monocot leaf explant, the monocot leaf explant comprising a heterologous polynucleotide expression cassette and a morphogenic gene expression cassette, wherein the morphogenic gene expression cassette comprises a nucleotide sequence encoding a functional WUS/WOX polypeptide and a nucleotide sequence encoding a Babyboom (BBM) polypeptide or an Ovule Development Protein 2 (ODP2) polypeptide or a functional homolog of a WUS/WOX and a BBM or ODP2 polypeptide, wherein the combined expression of the nucleotide sequence encoding the functional WUS/WOX polypeptide and the nucleotide sequence encoding the Babyboom (BBM) polypeptide or the Ovule Development Protein 2 (ODP2) polypeptide or the functional homolog of a WUS/WOX and a BBM or ODP2 polypeptide is adequate in strength and duration such that the monocot leaf explant forms a regenerable plant structure containing the heterologous polynucleotide expression cassette within about eight weeks or less, or within about 6 weeks or less, or within about 4 weeks or less, or within about ten days to about fourteen days of the monocot leaf explant receiving the heterologous polynucleotide expression cassette and the morphogenic gene expression cassette.

### Claim 26 (depends on 25)

The regenerable plant structure of claim 25, wherein the monocot leaf explant is a haploid monocot leaf explant.

### Claim 27 (depends on 25)

The regenerable plant structure of claim 25, wherein the nucleotide sequence encoding the functional WUS/WOX polypeptide is selected from WUS, WUS1, WUS2, WUS3, WOX2A, WOX4, WOX5A, and WOX9, and wherein the nucleotide sequence encoding the Babyboom (BBM) polypeptide is selected from BBM, BBM1, BBM2, BBM3, BMN2, and BMN3 or the Ovule Development Protein 2 (ODP2) polypeptide is ODP2.

### Claim 28 (depends on 25)

The regenerable plant structure of claim 25, wherein the heterologous polynucleotide expression cassette and the morphogenic gene expression cassette are introduced through a method of transformation by a Rhizobia bacterial species or particle bombardment.

### Claim 29 (depends on 25)

The regenerable plant structure of claim 25, wherein the heterologous polynucleotide expression cassette and the morphogenic gene expression cassette are introduced through a method of electroporation, PEG transfection, or RNP (ribonucleoprotein) delivery.

### Claim at position 26

30-42. (canceled)

### Claim 43 (depends on 25)

A fertile transgenic monocot plant produced from the regenerable plant structure of claim 25.

### Claim 44 (depends on 43)

The fertile transgenic monocot plant of claim 43, wherein the monocot plant does not comprise the morphogenic gene expression cassette.

### Claim 45 (depends on 43)

A plurality of monocot seeds produced from the transgenic monocot plant of claim 43.

### Claim 46

A method of producing a transgenic monocot plant that contains a heterologous polynucleotide comprising:
contacting a monocot leaf explant with a heterologous polynucleotide expression cassette and a morphogenic gene expression cassette, wherein the morphogenic gene expression cassette comprises a nucleotide sequence encoding a functional WUS/WOX polypeptide and a nucleotide sequence encoding a Babyboom (BBM) polypeptide or an Ovule Development Protein 2 (ODP2) polypeptide or a functional homolog of a WUS/WOX and a BBM or ODP2 polypeptide, wherein the combined expression of the nucleotide sequence encoding the functional WUS/WOX polypeptide and the nucleotide sequence encoding the Babyboom (BBM) polypeptide or the Ovule Development Protein 2 (ODP2) polypeptide is greater than the combined expression of the morphogenic gene expression cassette comprising the nucleotide sequence encoding the functional WUS/WOX polypeptide operably linked to the Agrobacterium-NOS promoter having SEQ ID NO: 290 and the nucleotide sequence encoding the Babyboom (BBM) polypeptide or the Ovule Development Protein 2 (ODP2) polypeptide operably linked to the ubiquitin (UBI) promoter having SEQ ID NO: 339;
selecting a monocot leaf explant containing the heterologous polynucleotide expression cassette, wherein the monocot leaf explant forms a regenerable plant structure containing the heterologous polynucleotide expression cassette within about eight weeks or less, or within about 6 weeks or less, or within about 4 weeks or less, or within about ten days to about fourteen days of the contacting; and
regenerating a transgenic monocot plant from the regenerable plant structure containing the heterologous polynucleotide expression cassette.

### Claim at position 31

47-111. (canceled)

### Claim 112

A method of producing a genome-edited maize plant comprising:
contacting a maize leaf explant with a morphogenic gene expression cassette, wherein the morphogenic gene expression cassette comprises a nucleotide sequence encoding a functional WUS/WOX polypeptide and a nucleotide sequence encoding a Babyboom (BBM) polypeptide or an Ovule Development Protein 2 (ODP2) polypeptide or a functional homolog of a WUS/WOX and a BBM or ODP2 polypeptide, wherein the combined expression of the nucleotide sequence encoding the functional WUS/WOX polypeptide and the nucleotide sequence encoding the Babyboom (BBM) polypeptide or the Ovule Development Protein 2 (ODP2) polypeptide or the functional homolog of a WUS/WOX and a BBM or ODP2 polypeptide is greater than the expression of the morphogenic gene expression cassette comprising the nucleotide sequence encoding the functional WUS/WOX polypeptide operably linked to the Agrobacterium-NOS promoter having SEQ ID NO: 290 and the nucleotide sequence encoding the Babyboom (BBM) polypeptide or the Ovule Development Protein 2 (ODP2) polypeptide operably linked to the ubiquitin (UBI) promoter having SEQ ID NO: 339;
providing a polynucleotide encoding a site-specific polypeptide or a site-specific nuclease;
selecting a maize leaf explant containing a genome edit, wherein the maize leaf explant forms a regenerable plant structure containing the genome edit within about eight weeks or less, or within about 6 weeks or less, or within about 4 weeks or less, or within about ten days to about fourteen days of the contacting; and
regenerating a genome-edited plant from the regenerable plant structure containing the genome edit.

### Claim at position 33

113-126. (canceled)
